Abstract
PET/MR imaging has the potential to markedly alter pancreatic care in both the malignant, and premalignant states with the ability to perform robust, high-resolution, quantitative molecular imaging. The ability of PET/MR imaging to monitor disease processes, potentially correct for motion in the upper abdomen, and provide novel biomarkers that may be a combination of MR imaging and PET biomarkers, offers a unique, precise interrogation of the pancreatic milieu going forward.
Original language | English (US) |
---|---|
Pages (from-to) | 345-362 |
Number of pages | 18 |
Journal | Magnetic Resonance Imaging Clinics of North America |
Volume | 26 |
Issue number | 3 |
DOIs | |
State | Published - Aug 1 2018 |
Keywords
- DOTATATE
- Neuroendocrine tumor
- Pancreas
- PET/MR imaging
ASJC Scopus subject areas
- Radiology Nuclear Medicine and imaging